PharmaDD Top News: Business, Technology, Strategic Briefings - Tracking leading techniques and approaches in therapeutic drug discovery and development

 

Sponsored Links:
Prescription Drug Addiction

 

 

Pharmaceutical Discovery, Oct 1, 2005 
Immobilization of Oligonucleotides on a Silicon Surface
By Patrizia Di Pietro , Enrico Alessi , Floriana San Biagio , Luigi La Magna , Gaetano Panvini , Gianfilippo Scicolone , Salvatore Oliveri , Salvo Coffa

Automating the digital ProteomeChip? -Filling Process: Microchip Technology, Synchronized Fluidics, and Motion Control
Pharmaceutical Discovery
An adaptive fluidic and motion control MetaModule™ from Parker Life Sciences ensures the accurate and reproducible formation and deposition of 200-nL volumes for the automated protein-profiling system, digital ProteomeChip™ (dPC), from Protein Forest, Inc.

Introduction

The protein-profiling market is currently dominated by 2-dimensional gel electrophoresis (2D GE), a technology hampered by low throughput and lack of reproducibility and resolution. Protein Forest, a life science products company based in Watertown, Massachusetts, overcame these problems by developing a unique technology, digital ProteomeChip™ (dPC), which accurately resolves proteins from cells, sera, and other complex mixtures. The automated profiling system combines a dPC used for each analysis, a benchtop instrument for running each 1D and 2D chip, and PC software for analyzing images into a highly accurate solution that helps researchers ensure reproducibility and avoid interpretation errors.

Protein Forest developed its chip technology for advanced protein separation, but also needed to synchronize motion control and fluidics using integrated software to dispense buffer polymers onto every dPC. Realizing there were no resources in-house to effectively develop a complex motion and fluidics solution, Protein Forest turned to Parker Life Sciences, a business unit within Parker Hannifin Corporation, to meet its engineering needs.

Results

 

Figure 1: Sample Formation (200 nL)
The systems engineering team developed a motion control and fluidics platform, the Parker MetaModule™, for precise droplet formation and deposition onto the dPC. Within five weeks, a complex solution was designed, demonstrating the first system to synchronize an X-Y-Z motion system and a syringe pump, both equipped with drivers, controllers, and cabling. A fully featured, software-programming language for controlling and synchronizing the motion and fluidics platform was also provided. In order to achieve the requirements to accurately and precisely create and dispense a 200-nL volume onto a glass substrate, Parker used its in-house testing services to conduct feasibility studies and to perform final system characterization.

 

Figure 2: Sample Deposition onto a Glass Substrate
The dPC is available in both small and large sizes with varying dimensions for holes, spacing, and volume. Taking into account the different chip sizes and needle dimensions, Parker designed the system and performed rigorous testing using drop formation, to compare diameter measurements and estimate volumes, ensuring high reproducibility (Figures 1 & 2). Qualifying this application ensured that the system would easily integrate with the dPC and allowed Protein Forest to focus on finalizing its own proprietary technology.

Conclusions

By taking advantage of Parker's engineering and scientific resources that combined system integration with rapid prototyping and application support services, Protein Forest saved time and money, greatly reducing overall project risks. This approach also allowed Protein Forest to maintain its resources on its core expertise.